18 May 2013
Keywords: generic, threat, augmentin, uk, smithkline, beecham, facing
Article | 06 June 1994
SmithKline Beecham is facing a potential challenge to an important
patent for its Augmentin (amoxicillin plus clavulanic acid) antibiotic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 June 1994
13 June 1994
17 May 2013
© 2013 thepharmaletter.com